evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes (Liraglutide) injection Novo's older obesity drug is

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

Hormonal modulators : buoyed by the success of therapeutically exploiting incretins, biotechs/pharma are exploring whether agonism of other GI hormones can similarly induce weight loss

What the published research reported A phase-2 randomized trial published in the New England Journal of Medicine in 2023 studied retatrutide in adults with obesity and reported substantial, dose-dependent reductions in body weight over 48 weeks, alongside a gastrointestinal side-effect profile broadly similar to other incretin drugs

K.GangopadhyayK

administration of exendin-4 into the 4th ventricle reduces food intake via reduction of meal frequency

H.TsengJ